NCT05943522Recruiting
Asciminib RMP Study
A Post Approval Surveillance of Scemblix® (Asciminib) in Patients With Chronic Myeloid Leukemia (CML) in Korea
Source: ClinicalTrials.gov · Last updated 20 Apr 2026
Brief summary (registry, in English)
This study is a prospective, open-label, multi-center, non-comparative, observational study to assess safety and effectiveness of Asciminib in the real-world clinical setting in Korean Chronic myeloid leukemia (CML) patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 5 Jul 2023
- Start date
- 19 Jul 2023
- Primary completion date
- 7 Jun 2030
- Lead sponsor
- Novartis Pharmaceuticals
- Diseases
- Chronic myeloid leukaemia
- NCT number
- NCT05943522
What you commit to
- Study type: Observational
- Planned participants: 600
- From 19 Jul 2023 to the primary completion date, 7 Jun 2030
- 11 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients with contraindication according to locally approved label of Scemblix®
- Patients who receive or are going to receive any investigational medicine during the observation period
Who the study is looking for
- Adult patients diagnosed with Ph+ CP-CML and currently receiving or going to receive Scemblix® treatment according to locally approval label
- Patients who are willing to provide written informed consent prior to study enrollment
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (11)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Anyang-si | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Bucheon-si | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Gyeonggi-do | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Incheon | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Jeollanam | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Pusan | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Suwon | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Taegu | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Uijeongbu-si | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Wŏnju | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.